Galimberti, S., Ciabatti, E., Ercolano, G., Grassi, S., Guerrini, F., Cecconi, N., . . . Petrini, M. (2017). The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study. Front Pharmacol.
Citação norma ChicagoGalimberti, Sara, et al. "The Combination of Rituximab and Bendamustine As First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study." Front Pharmacol 2017.
Citação norma MLAGalimberti, Sara, et al. "The Combination of Rituximab and Bendamustine As First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study." Front Pharmacol 2017.